(lp0
S"Catalyst Pharma shares jump 22% premarket on news of positive trial results ... MarketWatch - Mar 15, 2017 Shares of Catalyst Pharmaceuticals Inc. CPRX, +1.99% jumped 22% in premarket trade Wednesday, after the biotech reported positive data from a trial of a treatment for a form of myasthenia gravis, a rare neuromuscular disease, for which there is ...Catalyst Pharma positive trial data of a treatment for a rare neuromuscular ... - Proactive Investors USA & CanadaCatalyst Pharmaceuticals Inc : Here's What's Next - Market Exclusive"
p1
aS'Catalyst Pharmaceuticals, Inc. : A Detailed Look at its Institutional ... Post Analyst - 10 hours ago Catalyst Pharmaceuticals, Inc.  reached 201.96% versus a 1-year low price of $0.51. The stock was last seen 1.99% higher, reaching at $1.54 on Mar. 17, 2017.Catalyst Pharmaceuticals Inc  Earns Buy Rating from HC Wainwright - Sports PerspectivesThe Catalyst Pharmaceuticals Inc  Posts Quarterly Earnings Results ... - Petro Global News 24'
p2
aS"Roth Capital Weighs in on Catalyst Pharmaceuticals Inc  Following ... Smarter Analyst - Oct 13, 2016 Roth Capital analyst Scott Henry is out today with a research note on shares of Catalyst Pharmaceuticals Inc , following recent meeting with the company's senior management."
p3
aS'Catalyst Pharmaceuticals: Why This $1 Biotech Stock Is A Strong Buy For 2017 Seeking Alpha - Jan 4, 2017 I have recently found a couple of very interesting investment opportunities that offer an excellent risk to reward ratio and one of the stocks I am bullish on now is Catalyst Pharmaceuticals, Inc. . As we can see from the chart below, 2016 ...'
p4
aS'Broadfin Capital is Buying Catalyst Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 13, 2017 In a just published Form 13, filed with the US Securities and Exchange Commission , Catalyst Pharmaceuticals Inc.  reported that Broadfin Capital has picked up 8,200,000 of common stock as of 2017-02-13.'
p5
aS'Catalyst Pharma : What???s in Store in Q4 Earnings? Yahoo Finance - Mar 7, 2017 Catalyst Pharmaceuticals, Inc. CPRX is expected to report fourth-quarter 2016 results this month. Last quarter, the company recorded a positive earnings surprise of 16.67%.Catalyst Pharmaceutical Partners, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p6
aS"Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and ... GlobeNewswire  - Nov 9, 2016 CORAL GABLES, Fla., Nov. 09, 2016  -- Catalyst Pharmaceuticals, Inc.  , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases&nbsp;...Catalyst Pharmaceutical Partners'  CEO Patrick McEnany on Q3 2016 ... - Seeking Alpha"
p7
aS"Catalyst Pharma's neuromuscular drug succeeds in study Reuters - Mar 15, 2017 Catalyst Pharmaceuticals Inc said on Wednesday its experimental drug to treat patients with a severe form of myasthenia gravis , a rare neuromuscular disease, met the main goals of a study."
p8
aS"Company Update : Here's Why Catalyst Pharmaceuticals Inc Shares ... Smarter Analyst - Oct 31, 2016 cprx2 Catalyst Pharmaceuticals Inc  investors cheer the news that the biopharmaceutical company has reached an agreement with the FDA under a Special Protocol Assessment  for the protocol design, clinical endpoints, and statistical&nbsp;..."
p9
aS'Catalyst Pharmaceuticals Inc  to Release Earnings on Wednesday Chaffey Breeze - Mar 14, 2017 Catalyst Pharmaceuticals logo Catalyst Pharmaceuticals Inc  is scheduled to post its quarterly earnings results after the market closes on Wednesday, March 15th.'
p10
a.